Practical Two-Step Screening for Cystic Fibrosis Related Diabetes and prediabetes
Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
Cystic fibrosis-related diabetes and prediabetes (CFRD/CFRPD) worsen CF lung disease, but it is not know how best to detect these disorders. CFRD/CFRPD have no symptoms, so detection will require screening. This study will test if an alternative two-step strategy will appropriately screen for these disorders. This study will collect blood specimens.
>= 10 Years
>= Percent Predicted
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Must be at least six weeks since any previous use of glucocorticoids or intravenous antibiotics
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
FOR MORE INFORMATION:
Sponsor Contact Information:
Phillips, Lawrence (404) 727-1392 firstname.lastname@example.org
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.
Emory University (Pediatric), Atlanta, GA, 30322
Hunter, Eric Phone: (404) 785-3102 Email: email@example.com
The Minnesota Cystic Fibrosis Center (Pediatric), Minneapolis, MN, 55455
Grover, Patricia Phone: (612) 626-7425 Email: Grove026@umn.edu